FindTrial
Sign In

Differential expression profiles and pathological significance of CircRNAs in patients with rheumatoid arthritis

Differential expression profiles and pathological significance of CircRNAs in patients with rheumatoid arthritis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020256
Enrollment
Unknown
Registered
2018-12-21
Start date
2018-12-31
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Interventions

Health Control:Null
experiment group :Null

Sponsors

Department of Rheumatology and Immunology, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis of RA was confirmed by the diagnostic criteria of the American Academy of Rheumatology (ACR) for RA in 2009; 2. Signed the written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with other autoimmune diseases and major organ diseases; 2. There are various other situations in which researchers do not consider it possible to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
DAS28;CRP;ESR;RF;CCP;CDAI;SDAI;—

Countries

China

Contacts

Public ContactQibing Xie

West China Hospital, Sichuan University

xieqibing1975@163.com+86 18980601299

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026